Sort
130,381 grants matching “hiv”
International Epidemiologic Databases to Evaluate AIDS - Southern Africa (IeDEA-SA)
$2,500,000Matthias Egger · Universitat Bern · U01 · FY2016 · AI
COLLABORATIVE AIDS PROGRAMME OF RESEARCH IN SOUTH AFRICA
$2,500,000Salim S Abdool Karim · University Of Kwazulu-Natal · U19 · FY2006 · AI
SPORE in Cervical Cancer
$2,500,000Johns Hopkins University · P50 · FY2003 · CA
GH11-11112: IMPROVEMENT OF INTEGRATED HIV CLINICAL-BASED SERVICES
$2,500,000Jean William Pape · Gheskio Center · U2G · FY2014 · GH
Safety and Efficacy Eval of Microbicide/Biomedical Prevention in NHP SIV/SHIV Inf
$2,500,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2012 · AI
SUPPORTING THE SCALE-UP HIGH QUALITY HIV CARE AND TREATMENT PROGRAMS IN MALAWI
$2,499,999Dr. Steve Kamiza · University Of Malawi · U2G · FY2014 · PS
University of Puerto Rico Clinical Trials Unit
$2,499,265Carmen D Zorrilla · University Of Puerto Rico Med Sciences · UM1 · FY2013 · AI
THE ZIMBABWE-SAN FRANCISCO HIV PREVENTION TRIALS UNIT
$2,499,172University Of California San Francisco · U01 · FY2000 · AI
Third Coast Center for AIDS Research
$2,498,643Brian Mustanski · Northwestern University At Chicago · P30 · FY2025 · AI
Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults
$2,498,125Joshua D Lee · New York University School Of Medicine · U01 · FY2024 · DA
MyPEEPS Mobile LITE: Limited Interaction Efficacy Trial of MyPEEPS Mobile to Reduce HIV Incidence and Better Understand the Epidemiology of HIV among YMSM
$2,497,744Rebecca Schnall · Columbia University Health Sciences · UH3 · FY2024 · AI
University of Puerto Rico Clinical Trials Unit
$2,497,560Carmen D Zorrilla · University Of Puerto Rico Med Sciences · U01 · FY2011 · AI
PD-1 Function, Signaling, and Regulation During Viral Infection
$2,497,122Rafi Ahmed · Emory University · P01 · FY2011 · AI
Limited interaction cohort to identify determinants of viral suppression in MSM and transfeminine individuals living with HIV: A multilevel approach
$2,496,734Patrick Sean Sullivan · Emory University · UG3 · FY2024 · AI
IeDEA West -Africa collaboration
$2,496,231Francois Dabis · Adera · U01 · FY2012 · AI
PD-1 Function, Signaling, and Regulation During Viral Infection
$2,496,127Rafi Ahmed · Emory University · P01 · FY2012 · AI
Emory WIHS CRS - Longitudinal Cohort
$2,494,982Ighovwerha Ofotokun · Emory University · U01 · FY2015 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$2,494,558Judith S. Currier · University Of California Los Angeles · UM1 · FY2013 · AI
Adjuvant Development in the context of a vaccine to protect against tuberculosis
$2,494,333Vaxine Pty Ltd · N01 · FY2018 · AI
Single cell determinants of brain in the context of viral persistence in SIV/cART/cocaine non-human primates
$2,494,069Tariq M Rana · University Of California, San Diego · U01 · FY2023 · DA
Chicago Consortium Women's Interagency HIV Study lll
$2,493,775Hektoen Institute For Medical Research · U01 · FY2004 · AI
AIDS Linked to the IntraVenous Experience (ALIVE)
$2,493,073Shruti H Mehta · Johns Hopkins University · U01 · FY2021 · DA
Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication
$2,492,623Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2023 · AI
Obesogenic origins of maternal and child metabolic health involving dolutegravir (ORCHID)
$2,491,998Elaine Janine Abrams · Columbia University Health Sciences · R01 · FY2022 · HD
HSV-1 Amplicon Vectors for HIV Vaccine Delivery
$2,491,559University Of Rochester · P01 · FY2004 · AI